Endothelin-1 as a diagnostic and prognostic biomarker of subclinical anthracycline-induced vascular toxicity in lymphoproliferative diseases patients with low and intermediate cardiotoxic risk
Endothelin-1 is a promising early diagnostic and prognostic biomarker of subclinical anthracycline-induced vascular toxicity in lymphoma patients with low and intermediate CVT-risk receiving anthracycline-based chemotherapy and may facilitate early risk reclassification and optimization of cardio-oncology surveillance...